Annual Cash & Cash Equivalents
$4.74 M
-$5.10 M-51.85%
31 December 2023
Summary:
Evoke Pharma annual cash & cash equivalents is currently $4.74 million, with the most recent change of -$5.10 million (-51.85%) on 31 December 2023. During the last 3 years, it has fallen by -$3.33 million (-41.26%). EVOK annual cash & cash equivalents is now -80.41% below its all-time high of $24.20 million, reached on 31 December 2013.EVOK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$11.34 M
+$2.16 M+23.55%
30 September 2024
Summary:
Evoke Pharma quarterly cash and cash equivalents is currently $11.34 million, with the most recent change of +$2.16 million (+23.55%) on 30 September 2024. Over the past year, it has increased by +$5.37 million (+90.10%). EVOK quarterly cash and cash equivalents is now -53.14% below its all-time high of $24.20 million, reached on 31 December 2013.EVOK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVOK Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.9% | +90.1% |
| 3 y3 years | -41.3% | +1.8% |
| 5 y5 years | -10.9% | +74.3% |
EVOK Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.9% | at low | -15.7% | +139.3% |
| 5 y | 5 years | -51.9% | at low | -37.6% | +174.3% |
| alltime | all time | -80.4% | +3985.7% | -53.1% | +9675.0% |
Evoke Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.34 M(+23.5%) |
| June 2024 | - | $9.18 M(-5.4%) |
| Mar 2024 | - | $9.70 M(+104.7%) |
| Dec 2023 | $4.74 M(-51.9%) | $4.74 M(-20.5%) |
| Sept 2023 | - | $5.96 M(-14.9%) |
| June 2023 | - | $7.01 M(-14.7%) |
| Mar 2023 | - | $8.21 M(-16.6%) |
| Dec 2022 | $9.84 M(+7.6%) | $9.84 M(-20.3%) |
| Sept 2022 | - | $12.35 M(-8.2%) |
| June 2022 | - | $13.45 M(+74.7%) |
| Mar 2022 | - | $7.70 M(-15.8%) |
| Dec 2021 | $9.14 M(+13.3%) | $9.14 M(-17.9%) |
| Sept 2021 | - | $11.14 M(-33.4%) |
| June 2021 | - | $16.72 M(-8.1%) |
| Mar 2021 | - | $18.19 M(+125.4%) |
| Dec 2020 | $8.07 M(+42.5%) | $8.07 M(+28.5%) |
| Sept 2020 | - | $6.28 M(-21.4%) |
| June 2020 | - | $7.99 M(+93.3%) |
| Mar 2020 | - | $4.13 M(-27.0%) |
| Dec 2019 | $5.66 M(+6.5%) | $5.66 M(-12.9%) |
| Sept 2019 | - | $6.50 M(-12.6%) |
| June 2019 | - | $7.44 M(+84.7%) |
| Mar 2019 | - | $4.03 M(-24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $5.32 M(-30.7%) | $5.32 M(-19.0%) |
| Sept 2018 | - | $6.57 M(+0.6%) |
| June 2018 | - | $6.53 M(+20.8%) |
| Mar 2018 | - | $5.41 M(-29.6%) |
| Dec 2017 | $7.68 M(-14.7%) | $7.68 M(-26.3%) |
| Sept 2017 | - | $10.41 M(-17.1%) |
| June 2017 | - | $12.56 M(-14.3%) |
| Mar 2017 | - | $14.65 M(+62.7%) |
| Dec 2016 | $9.01 M(+3.6%) | $9.01 M(-13.2%) |
| Sept 2016 | - | $10.38 M(+151.4%) |
| June 2016 | - | $4.13 M(-32.3%) |
| Mar 2016 | - | $6.10 M(-29.8%) |
| Dec 2015 | $8.69 M(-38.6%) | $8.69 M(-19.1%) |
| Sept 2015 | - | $10.74 M(+8.7%) |
| June 2015 | - | $9.88 M(-15.5%) |
| Mar 2015 | - | $11.69 M(-17.4%) |
| Dec 2014 | $14.16 M(-41.5%) | $14.16 M(+16.3%) |
| Sept 2014 | - | $12.18 M(-24.1%) |
| June 2014 | - | $16.05 M(-26.5%) |
| Mar 2014 | - | $21.84 M(-9.8%) |
| Dec 2013 | $24.20 M(>+9900.0%) | $24.20 M(+1.9%) |
| Sept 2013 | - | $23.74 M(>+9900.0%) |
| Dec 2012 | $116.00 K(-86.6%) | $116.00 K |
| Dec 2011 | $865.90 K | - |
FAQ
- What is Evoke Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Evoke Pharma?
- What is Evoke Pharma annual cash & cash equivalents year-on-year change?
- What is Evoke Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Evoke Pharma?
- What is Evoke Pharma quarterly cash and cash equivalents year-on-year change?
What is Evoke Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of EVOK is $4.74 M
What is the all time high annual cash & cash equivalents for Evoke Pharma?
Evoke Pharma all-time high annual cash & cash equivalents is $24.20 M
What is Evoke Pharma annual cash & cash equivalents year-on-year change?
Over the past year, EVOK annual cash & cash equivalents has changed by -$5.10 M (-51.85%)
What is Evoke Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EVOK is $11.34 M
What is the all time high quarterly cash and cash equivalents for Evoke Pharma?
Evoke Pharma all-time high quarterly cash and cash equivalents is $24.20 M
What is Evoke Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, EVOK quarterly cash and cash equivalents has changed by +$5.37 M (+90.10%)